Novavax, Inc.
MX ˙ BMV ˙ US6700024010
SecurityMX:NVAX / Novavax, Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership129,750 shares
Latest Disclosed Value $ 1,056,165
Deutsche Bank Ag\ ownership in NVAX / Novavax, Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 129,750 shares of Novavax, Inc. (MX:NVAX) valued at $1,056,165 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 119,924 shares of Novavax, Inc.. This represents a change in shares of 8.19% during the quarter.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (NVAX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NVAX / Novavax, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F NOVAVAX COM NEW 670002401 129,750 9,826 8.19 1,056 31.18 0.0003
2026-02-11 2025-12-31 13F NOVAVAX COM NEW 670002401 119,924 4,904 4.26 806 -19.26 0.0003
2025-11-13 2025-09-30 13F NOVAVAX COM NEW 670002401 115,020 14,082 13.95 997 57.01 0.0003
2025-08-12 2025-06-30 13F NOVAVAX COM NEW 670002401 100,938 -15,779 -13.52 636 -15.11 0.0002
2025-05-09 2025-03-31 13F NOVAVAX COM NEW 670002401 116,717 -6,864 -5.55 748 -24.67 0.0003
2025-06-30 2024-12-31 13F/A-1 NOVAVAX COM NEW 670002401 123,581 39,787 47.48 994 -6.14 0.0004
2025-02-14 2024-12-31 13F NOVAVAX COM NEW 670002401 123,581 39,787 994 0.0004
2025-06-26 2024-09-30 13F/A-1 NOVAVAX COM NEW 670002401 83,794 18,572 28.48 1,058 28.24 0.0004
2024-11-13 2024-09-30 13F NOVAVAX COM NEW 670002401 83,794 18,572 1,058 0.0004
2025-06-12 2024-06-30 13F/A-1 NOVAVAX COM NEW 670002401 65,222 7,403 12.80 826 198.91 0.0004
2024-08-14 2024-06-30 13F NOVAVAX COM NEW 670002401 65,222 7,403 826 0.0004
2025-06-02 2024-03-31 13F/A-1 NOVAVAX COM NEW 670002401 57,819 11,652 25.24 276 24.89 0.0001
2024-05-15 2024-03-31 13F NOVAVAX COM NEW 670002401 57,819 11,652 276 0.0001
2024-02-14 2023-12-31 13F NOVAVAX COM NEW 670002401 46,167 -736 -1.57 222 -34.81 0.0001
2023-11-24 2023-09-30 13F/A-1 NOVAVAX COM NEW 670002401 46,903 5,515 13.33 340 10.42 0.0002
2023-11-09 2023-09-30 13F NOVAVAX COM NEW 670002401 46,903 5,515 340 0.0002
2023-08-14 2023-06-30 13F NOVAVAX COM NEW 670002401 41,388 27,730 203.03 308 226.60 0.0002
2023-05-15 2023-03-31 13F NOVAVAX COM NEW 670002401 13,658 -58,207 -80.99 95 -87.26 0.0001
2023-02-13 2022-12-31 13F NOVAVAX COM NEW 670002401 71,865 5,084 7.61 739 -39.26 0.0004
2022-11-14 2022-09-30 13F NOVAVAX COM NEW 670002401 66,781 -11,144 -14.30 1,215 -69.69 0.0007
2022-08-11 2022-06-30 13F NOVAVAX COM NEW 670002401 77,925 -119,957 -60.62 4,008 -72.50 0.0022
2022-05-13 2022-03-31 13F NOVAVAX COM NEW 670002401 197,882 26,037 15.15 14,574 -40.72 0.0068
2022-02-16 2021-12-31 13F/A-1 NOVAVAX COM NEW 670002401 171,845 53,766 45.53 24,585 0.43 0.0111
2022-02-11 2021-12-31 13F NOVAVAX COM NEW 670002401 171,845 53,766 24,585 0.0110
2021-11-04 2021-09-30 13F NOVAVAX COM NEW 670002401 118,079 -1,943 -1.62 24,480 -3.93 0.0116
2021-08-11 2021-06-30 13F NOVAVAX COM NEW 670002401 120,022 45,305 60.64 25,482 88.10 0.0124
2021-05-13 2021-03-31 13F NOVAVAX COM NEW 670002401 74,717 -2,291 -2.98 13,547 57.76 0.0073
2021-02-16 2020-12-31 13F NOVAVAX COM NEW 670002401 77,008 36,808 91.56 8,587 97.13 0.0052
2020-11-12 2020-09-30 13F NOVAVAX COM NEW 670002401 40,200 5,780 16.79 4,356 51.83 0.0030
2020-08-13 2020-06-30 13F NOVAVAX COM NEW 670002401 34,420 24,051 231.95 2,869 1,934.75 0.0022
2020-05-14 2020-03-31 13F NOVAVAX COM NEW 670002401 10,369 1,273 14.00 141 302.86 0.0001
2020-02-14 2019-12-31 13F NOVAVAX COM NEW 670002401 9,096 2,845 45.51 35 16.67 0.0000
2019-11-14 2019-09-30 13F NOVAVAX COM NEW 670002401 6,251 -74,810 -92.29 30 -93.67 0.0000
2019-08-14 2019-06-30 13F NOVAVAX COM NEW 670002401 81,061 -3,040,542 -97.40 474 -72.43 0.0003
2019-05-15 2019-03-31 13F NOVAVAX COM 670002104 3,121,603 2,358,173 308.89 1,719 22.44 0.0010
2019-04-01 2018-12-31 13F/A-1 NOVAVAX COM 670002104 763,430 -1,035,886 -57.57 1,404 -58.50 0.0010
2019-02-14 2018-12-31 13F NOVAVAX COM 670002104 763,430 -302,517 1,404
2021-12-21 2018-09-30 13F/A-1 NOVAVAX COM 670002104 1,799,316 455,186 33.86 3,383 87.84 0.0017
2018-11-14 2018-09-30 13F NOVAVAX COM 670002104 1,065,947 -278,183 2,003 0.0014
2020-04-21 2018-06-30 13F/A-1 NOVAVAX COM 670002104 1,344,130 -4,483,617 -76.94 1,801 -85.28 0.0009
2018-08-14 2018-06-30 13F NOVAVAX COM 670002104 1,162,868 -4,664,879 1,557 1,034.1555
2019-10-23 2018-03-31 13F/A-2 NOVAVAX COM 670002104 5,827,747 3,260,578 127.01 12,236 284.54 0.0058
2019-10-18 2018-03-31 13F/A-1 NOVAVAX COM 670002104 5,827,747 0 12,236 0.0058
2018-05-15 2018-03-31 13F NOVAVAX COM 670002104 4,676,863 2,109,694 9,819
2018-02-14 2017-12-31 13F NOVAVAX COM 670002104 2,567,169 152,974 6.34 3,182 15.71 0.0020
2017-11-14 2017-09-30 13F NOVAVAX COM 670002104 2,414,195 1,525,063 171.52 2,750 169.34 0.0019
2017-08-11 2017-06-30 13F NOVAVAX COM 670002104 889,132 -385,176 -30.23 1,021 -37.32 0.0007
2017-05-15 2017-03-31 13F NOVAVAX COM 670002104 1,274,308 515,584 67.95 1,629 70.75 0.0012
2017-02-14 2016-12-31 13F NOVAVAX COM 670002104 758,724 127,977 20.29 954 -27.23 0.0008
2016-11-14 2016-09-30 13F NOVAVAX COM 670002104 630,747 -791,508 -55.65 1,311 -87.32 0.0009
2016-08-15 2016-06-30 13F NOVAVAX COM 670002104 1,422,255 582,552 69.38 10,338 138.64 0.0073
2016-05-16 2016-03-31 13F NOVAVAX COM 670002104 839,703 32,680 4.05 4,332 -36.00 0.0033
2016-02-16 2015-12-31 13F NOVAVAX COM 670002104 807,023 -411,731 -33.78 6,769 -21.43 0.0047
2015-11-17 2015-09-30 13F NOVAVAX COM 670002104 1,218,754 463,265 61.32 8,615 2.39 0.0067
2015-08-12 2015-06-30 13F NOVAVAX COM 670002104 755,489 -41,315 -5.19 8,414 27.72 0.0054
2015-05-15 2015-03-31 13F NOVAVAX COM 670002104 796,804 442,346 124.80 6,588 213.71 0.0041
2015-02-13 2014-12-31 13F NOVAVAX COM 670002104 354,458 312,200 738.80 2,100 1,100.00 0.0013
2014-11-14 2014-09-30 13F NOVAVAX COM 670002104 42,258 1,235 3.01 175 -6.91 0.0001
2014-08-15 2014-06-30 13F NOVAVAX COM 670002104 41,023 -16,718 -28.95 188 -27.97 0.0001
2014-05-15 2014-03-31 13F NOVAVAX COM 670002104 57,741 -61,645 -51.64 261 -57.21 0.0002
2014-02-24 2013-12-31 13F/A-1 NOVAVAX COM 670002104 119,386 -245,211 -67.26 610 -46.86 0.0004
2014-02-18 2013-12-31 13F NOVAVAX COM 670002104 119,386 610
2013-11-18 2013-09-30 13F NOVAVAX COM 670002104 364,597 54,068 17.41 1,148 80.79 0.0008
2013-08-16 2013-06-30 13F NOVAVAX COM 067000210 310,529 310,529 635 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-08-15 2014-06-30 13F NOVAVAX COM Call 0 -100.00 0 n/a n/a n/a
2014-05-15 2014-03-31 13F NOVAVAX COM Call 650 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.